In vivo formation of 8-iso-prostaglandin and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation

Circulation

Volumn 99, Issue 2, 1999, Pages 224-229

  Davì, Giovanni ^a   Ciabattoni, Giovanni ^b   Consoli, Agostino ^a   Mezzetti, Andrea ^a   Falco, Antonio ^b   Santarone, Stella ^a   Pennese, Elsa ^a   Vitacolonna, Ester ^a   Bucciarelli, Tonino ^a   Costantini, Fabrizio ^a   Capani, Fabio ^a   Patrono, Carlo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antioxidants; Diabetes mellitus; Lipids; Platelets; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; INDOBUFEN; METFORMIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; URINARY EXCRETION; VITAMIN SUPPLEMENTATION;

EID: 0032905015     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.2.224     Document Type: Article

References (33)

1. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes. 1987;3:463-524.
2. Palinski W, Witztum JL. Oxidative stress and diabetes mellitus. In: Schwartz CJ, Born GVR, eds. New Horizons in Diabetes Mellitus and Cardiovascular Disease. London: Rapid Science Publishers; 1996:81-93.
3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
4. Chisolm GM, Irwin KC, Penn MS. Lipoprotein oxidation and lipoprotein-induced injury in diabetes. Diabetes. 1992;4:61-66.
5. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 1994;43:1010-1014.
6. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387.
7. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 1997; 17:2309-2315.
8. 2 receptors. J Clin Invest. 1992;90:136-141.
9. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 1992;44:155-163.
10. 2 receptors in human platelets. J Pharmacol Exp Ther. 1994;270:1192-1196.
11. Praticò D, Smyth EM, Violi F, FitzGerald GA. Local amplification of platelet function by 8-epi-prostaglandin F2α is not mediated by thromboxane receptor isoforms. J Biol Chem. 1996;271:14916-14924.
12. Awad JA, Morrow JD, Takahashi K, Roberts LJ. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem. 1993;268:4161-4169.
13. 2α excretion in man. J Pharmacol Exp Ther. 1995;275:94-100.
14. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230-3235.
15. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
16. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 1996;94:19-25.
17. Davì G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28: 1039-1057.
19. 2 in human plasma and urine. Biochim Biophys Acta. 1987;918:293-297.
20. van Kooten F, Ciabattoni G, Patrono C, Dippel DWJ, Koudstaal PJ. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke. 1997;28:1557-1563.
21. Davì G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo: evidence derived from the study of peripheral arterial disease. Circulation. 1997;96:69-75.
22. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ. Relationship between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 1997; 40:647-653.
23. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes. 1997;46:1853-1858.
24. Cominacini L, Fratta Pasini A, Garbin U, Camapagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V. E-selectin plasma concentration is influenced by glycemic control in NIDDM patients: possible role of oxidative stress. Diabetologia. 1997;40:584-589.
25. Jenkins AJ, Klein RL, Chassereau CN, Hermayer KL, Lopes-Virella MF. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes. 1996;45:762-767.
26. Sanchez-Quesada JL, Perez A, Caixas A, Ordonmez-Llanos J, Carreras G, Payes A, Gonzales-Sastre F, de-Leiva A. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia. 1996;39: 1469-1476.
27. Yoshida H, Ishikawa T, Nakamura H. Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non insulin dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1997;17:1438-1446.
28. 2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors. Am J Physiol. 1996;271:H159-H165.
29. 2α levels are elevated in individuals with non-insulin-dependent diabetes mellitus. FEBS Lett. 1995;368: 225-229.
30. Catella-Lawson F, Kapoor S, Praticó D, Braunstein SN, Caraballo V, FitzGerald GA. Oxidative stress and diabetes mellitus. J Invest Med. 1996;44:223A. Abstract.
31. 2α increases adhesion and reduces the antiadhesive and antiaggregatory effects of nitric oxide. Arterioscler Thromb Vasc Biol. 1998;18:1248-1256.
32. Maclouf J, Folco G, Patrono C. Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease. Thromb Haemost. 1998;79:691-705.
33. Patrono C, Davì G. Antiplatelet agents in the prevention of diabetic vascular complications. Diabetes Metab Rev. 1993;9:177-188.